Taking aim at disease

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus
ORNL radioisotope manufacturing coordinator Jillene Sennon-Greene places a shipment vial of actinium-225 inside the dose calibrator to confirm its activity is within customer specifications. (Photo: Carlos Jones/ORNL, DOE)

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.

That tiny amount of the radioisotope was purchased by the hospital for use in cancer studies. And it heralded a new peacetime mission for ORNL, built just a few years earlier for the production of plutonium from uranium for the Manhattan Project.

Nucleus RadioPharma to receive Lu-177 under agreement with SHINE

November 21, 2023, 12:00PMNuclear News

Wisconsin-based fusion technology company SHINE Technologies has signed a long-term supply agreement with Nucleus RadioPharma for the supply of lutetium-177, a radioisotope used in cancer treatment therapies, including those in development for the treatment of neuroendocrine tumors, prostate cancer, and other solid tumors.

Missouri’s MURRs: Old and new

August 23, 2023, 9:30AMNuclear News
A reactor operator at MURR works with a sample can from the reactor pool. (Photo: University of Missouri)

On April 10, the University of Missouri (MU) took its first formal step toward building NextGen MURR when school officials issued the request for qualifications for the project. The RFQ is a solicitation for interested companies to offer the design, engineering, licensing, environmental, and developmental services that are needed for NextGen MURR, planned to be larger and more capable than the school’s existing University of Missouri Research Reactor (MURR)—which itself has been the most powerful research reactor and most intense neutron source on any U.S. campus since it began operating in 1966.

White House official talks strategy for securing civilian radioactive materials

March 7, 2023, 12:10PMANS Nuclear Cafe

Sherwood-Randall

The Biden administration on March 2 announced a new strategy to remove and secure certain highly radioactive materials that are used in hospitals and other civilian commercial facilities as a measure to prevent such materials from being acquired by terrorists for making “dirty bombs” or other weapons. Elizabeth Sherwood-Randall, White House assistant to the president for Homeland Security, shared the details of the National Security Memorandum to Counter Weapons of Mass Destruction Terrorism and Advance Nuclear and Radioactive Material Security (NSM19) later that same day in a discussion at the Nuclear Threat Initiative (NTI) global security organization in Washington, D.C., according to a report in the New York Times.

National strategy: Biden’s newly signed NSM 19 “integrates, in a systematic way, U.S. policies to counter the use of chemical, biological, radiological, and nuclear weapons by non-state actors; sets out unified priorities for Departments and Agencies across the Federal government; and affirms the Biden-Harris Administration’s commitment to work with state, local, tribal, international, and private sector partners on preventing, mitigating, and responding to WMD terrorism threats.”

NorthStar completes construction of Mo-99 production facility

December 6, 2022, 7:01AMNuclear News
The electron accelerator that will be used for Mo-99 production at NorthStar’s newly completed facility in Wisconsin. (Photo: NNSA)

NorthStar Medical Radioisotopes has completed construction and all equipment installation at its new facility in Beloit, Wis., to produce the medical radioisotope molybdenum-99 without the use of high-enriched uranium, the Department of Energy’s National Nuclear Security Administration announced last week.

New method produces curium crystals for research in a radiochemistry first

September 21, 2022, 7:00AMNuclear News
A new compound of curium photographed at LLNL during crystallography experiments. Crystals of this curium compound are uncolored under ambient light but glow an intense pink-red when exposed to ultraviolet light. (Image: LLNL/Deblonde)

Scientists at Lawrence Livermore National Laboratory and Oregon State University (OSU) have developed a promising new method to isolate and study some of the rarest elements on Earth. Focused first on curium, they have identified three new complexes containing curium ions and revealed the molecules’ 3D structures, as well as previously unknown features.

ANS panel discussion focuses on nuclear technologies for space commercialization and exploration

August 8, 2022, 9:30AMANS News
This landscape speckled with glittering stars is the edge of a nearby, young, star-forming region called NGC 3324 in the Carina Nebula. Captured in infrared light by NASA’s new James Webb Space Telescope, this image reveals for the first time previously invisible areas of star birth. (Photo: NASA)

ANS’s August 4 online event “The New Space Race is Going Nuclear” featured several expert panelists who discussed the growing importance of nuclear technologies in space commercialization and exploration. Although nuclear energy has long played a role in space missions, participants discussed the latest exciting developments in the space nuclear field and presented their views on how increased application of nuclear technologies could fundamentally transform the ways in which both crewed and uncrewed space missions are carried out.

Webinar: International isotope supply chain needs coordination, not complacency

June 1, 2022, 9:30AMNuclear News

Accelerators and other new facilities are producing an increasing share of the radioisotopes that were once sourced solely from a handful of research reactors around the globe; demand for alpha-emitters is increasing; and the need for an ensured supply of both radioactive and stable isotopes is now heightened as many countries seek an alternative to Russian isotopes. Those are just a few of the key points that emerged from a recent webinar, “Demand and Supply of Isotopes Around the World: From Diverse Perspectives,” organized by the World Council of Isotopes, along with the Sylvia Fedoruk Canadian Centre for Nuclear Innovation and the University of Saskatchewan, the hosts of the upcoming 11th International Conference on Isotopes (11ICI).

Defense agency invests in fusion- and radioisotope-powered space propulsion

May 19, 2022, 9:30AMNuclear News
Artist’s rendering of USNC spacecraft using EmberCore. (Image: DIU)

The Defense Innovation Unit (DIU), a Department of Defense organization focused on swiftly putting commercial technology to use in the U.S. military, has awarded contracts for two nuclear technologies—compact fusion and radioisotope heat—for spacecraft that could carry a high-power payload and freely maneuver in cislunar space. The objective is to accelerate ground and flight testing and launch a successful orbital prototype demonstration of each approach in 2027.

IAEA combats crop-threatening banana wilt with nuclear technology

January 6, 2022, 3:00PMNuclear News
In 2021, the Fusarium wilt disease continued to spread in banana plantations across South America. (Photo: M.Dita/Biodiversity International, Colombia)

A lethal banana disease, known as the Fusarium wilt or Panama wilt, is spreading rapidly in South America and threatening global supplies of the Cavendish banana, the world’s most popular export variety. Working with experts in the Andean countries of Bolivia, Colombia, Ecuador, and Peru, the IAEA and the Food and Agriculture Organization of the United Nations (FAO) are using irradiation and nuclear-derived techniques to combat, manage, and prevent the spread of the disease. The IAEA describes the work in a December 24 news article.

Supply of Mo-99 sufficient to meet U.S. needs, feds say

December 21, 2021, 9:23AMNuclear News

Secretary of energy Jennifer Granholm and secretary of health and human services (HHS) Xavier Becerra on December 20 jointly certified that the worldwide supply of the medical radioisotope molybdenum-99 produced without the use of high-enriched uranium is now sufficient to meet the needs of patients in the United States.

Texas A&M to lead isotope R&D traineeship program

December 9, 2021, 9:31AMNuclear News

The Department of Energy is dedicating $2 million to the establishment of a first-of-its-kind program to train undergraduate and graduate students in isotope research and development, production, and processing. Texas A&M University will serve as the Isotope Traineeship Coordination (ITC) site, collaborating with a team of 14 colleges and universities and three national laboratories: Argonne National Laboratory, Lawrence Livermore National Laboratory, and Los Alamos National Laboratory.

NNSA issues Mo-99 cooperative agreement to Niowave

December 6, 2021, 3:00PMNuclear News

The Department of Energy’s National Nuclear Security Administration has issued a cooperative agreement worth $13 million to Niowave, of Lansing, Mich., to support the commercial production of molybdenum-99, a critical isotope used in more than 40,000 medical procedures in the United States each day, including the diagnosis of heart disease and cancer.

Researchers adapt Cf-252 source for wireless data transmission

November 15, 2021, 7:01AMNuclear News
(CLICK IMAGE TO ENLARGE) The researchers’ experimental layout is depicted here. In (b), the neutron chopper is depicted without the mesh guard shown in (d), a photograph of the experimental layout that includes the Cf-252 source tank at left. (Composite image: Joyce, et al., “Wireless information transfer with fast neutrons,” doi.org/10.1016/j.nima.2021.165946)

Swapping conventional electromagnetic radiation for fast neutrons, a team of research engineers at Lancaster University in the United Kingdom, working with the Jozef Stefan Institute of Slovenia, report that they have successfully transmitted digital information wirelessly using nuclear radiation. The researchers’ attempts to transmit words and numbers using standard ASCII code “were 100 percent successful,” according to a November 10 press release from Lancaster University. Their research will be published in an upcoming issue of Nuclear Instruments and Methods in Physics Research and is now available online.

Canada authorizes Mo-99 production at Darlington station

November 12, 2021, 9:30AMNuclear News
Darlington nuclear power plant. (Photo: OPG)

The Canadian Nuclear Safety Commission (CNSC) has amended Ontario Power Generation’s (OPG) operating license for its Darlington nuclear power station near Clarington, Ontario, allowing the company to produce the medical radioisotope molybdenum-99 using Darlington’s Unit 2 CANDU reactor. OPG subsidiary Laurentis Energy Partners, in conjunction with BWXT Medical, is leading the program to produce Mo-99 at Darlington.

Radioisotopes: The unseen infrastructure

October 29, 2021, 7:00AMANS Nuclear CafeMatt Reiter

What is one thing that bridges, oil wells, and cancer treatment therapies have in common? Reliance on radioisotopes. Radioisotopes have played an important role in our society for decades, yet their benefits often go unrecognized. As Congress makes progress on new bipartisan infrastructure legislation, radioisotopes are essential to bringing new infrastructure projects to life.

NNSA awards SHINE $35 million for Mo-99 production

October 19, 2021, 2:34PMNuclear News
SHINE Technologies’ headquarters building in Janesville, Wis. (Photo: SHINE)

The Department of Energy’s National Nuclear Security Administration has issued a cooperative agreement worth $35 million to SHINE Technologies, based in Janesville, Wis., to support the commercial production of molybdenum-99, a critical isotope used in more than 40,000 medical procedures in the United States each day, including the diagnosis of heart disease and cancer.

ARTMS submits Ga-68 radioisotope production paperwork with Health Canada

October 18, 2021, 12:00PMNuclear News
A PET imaging machine. (Photo: Wikimedia Commons)

ARTMS, a Canadian producer of medical isotopes, announced that it has registered the cyclotron production of gallium-68 with the government of Canada, filing a Type 1 Master File with the Health Products & Food Branch of Health Canada. The Ga-68 radioisotope is used in nuclear medicine diagnostic procedures utilizing positron emission tomography (PET) imaging.